RxDoctor Payments Data
★ My doctorsLook up a doctor →

von Hoang

Family · Walnut Creek, CANPI 1275921223

Payments from drug & device makers

$9,190in general payments, 2019–2025

Across 415 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$863
  • AstraZeneca$714
  • GSK$640
  • Amgen$531
  • Seagen Inc.$463
  • E.r. Squibb & Sons, L.L.C.$389
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$8,70295%
  • Education$4885%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc43$863
AstraZeneca(2 entities)27$714
GSK33$640
Amgen17$531
Seagen Inc.19$463
E.r. Squibb & Sons, L.L.C.14$389
Gilead(2 entities)19$386
Pharmacyclics LLC, An Abbvie Company17$370
Johnson & Johnson24$355
Puma Biotechnology, Inc.11$322
Pfizer15$284
Myovant Sciences Inc.13$283
Lilly USA, LLC8$261
Daiichi Sankyo Inc.8$237
Sanofi10$219
Novartis9$193
AbbVie5$188
Genentech USA, Inc.10$184
Eisai Inc.7$141
Bristol Myers Squibb7$134
Takeda Pharmaceuticals U.S.A., Inc.11$114
Incyte Corporation6$112
Sumitomo Pharma America, Inc.1$111
Regeneron Healthcare Solutions, Inc.4$101
Tersera Therapeutics LLC5$98
Sanofi-aventis U.S. LLC1$85
Bayer4$84
Beigene USA, Inc.4$67
Boehringer Ingelheim3$64
Acrotech Biopharma Inc.3$63
EMD Serono, Inc.3$59
Deciphera Pharmaceuticals Inc.3$58
Rigel Pharmaceuticals, Inc.3$58
Servier Pharmaceuticals LLC3$57
Array Biopharma Inc4$55
Taiho Oncology, Inc.3$54
Heron Therapeutics, Inc.3$51
Clovis Oncology, Inc.3$49
Ipsen Biopharmaceuticals, Inc2$48
Merck2$46
Blue Earth Diagnostics2$45
Epizyme, Inc.2$44
AVEO Pharmaceuticals, Inc.2$44
Kyowa Kirin, Inc.2$41
AMAG Pharmaceuticals, Inc.2$39
Dova Pharmaceuticals2$39
Dendreon Pharmaceuticals LLC1$33
Sobi, Inc1$32
Tactile Systems Technology Inc2$30
Pharmaessentia USA Corporation1$30
Jazz Pharmaceuticals Inc.1$25
Acceleron Pharma, Inc.1$23
Blueprint Medicines Corporation1$23
Karyopharm Therapeutics Inc.1$22
Apellis Pharmaceuticals, Inc.1$22
Myriad Genetic Laboratories, Inc.1$21
G1 Therapeutics, Inc.1$20
Exelixis Inc.1$20
Accord Healthcare, Inc.1$19
Sun Pharmaceutical Industries Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,190 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Medicare billing

Part B allowed, 2024
$29,844
Medicare patients
114
Services billed
448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Walnut Creek

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →